Global Burden of the Key Components of Cardiovascular-Kidney-Metabolic Syndrome
Глобальное бремя ключевых компонентов кардиоваскулярно-почечно-метаболического синдрома
2025-03-05
SCID: 54.1/yjbmcghf
Discuss with AI
Global Burden of Disease 2021NORDPRED modelcardiovascular-kidney-metabolic syndromedisability-adjusted life yearsischemic heart disease
Figures from the paper
Abstract (AI)
Key Points Ischemic heart disease and stroke were the leading contributors to the cardiovascular-kidney-metabolic (CKM) syndrome–related burden in 2021. Regions with a middle sociodemographic index, such as Southeast Asia and the Western Pacific, faced the highest burden. The burden of CKM syndrome is substantial and projected to rise through 2046, highlighting the need for targeted interventions. Background Cardiovascular-kidney-metabolic (CKM) syndrome highlights the interconnected nature of metabolic diseases, CKD, and cardiovascular diseases, representing a significant and growing public health burden. This study aimed to quantify the global burden of CKM syndrome by examining its key components, including high body mass index, diabetes, CKD, atrial fibrillation and flutter, lower extremity peripheral arterial disease, ischemic heart disease, and stroke. Methods Data were derived from the Global Burden of Disease 2021 platform, which provided estimates for incidence, prevalence, mortality, years lived with disability, years of life lost, and disability-adjusted life years (DALYs). A decomposition analysis was performed to assess the contributions of population growth, aging, and epidemiologic changes to the burden of CKM syndrome. A NORDPRED model was used to project future trends in DALYs, years of life lost, and years lived with disability through 2046. Results Globally, ischemic heart disease and stroke were the major contributors to the CKM syndrome–related burden in 2021. Regions with a middle sociodemographic index (SDI), such as Southeast Asia and the Western Pacific, experienced the largest burden. However, age-standardized DALY rates were inversely related to SDI, with regions of lower SDI exhibiting higher rates. From 1990 to 2021, DALYs for the seven key components of CKM syndrome increased, primarily driven by population growth and aging. However, age-standardized DALY rates varied across components, with stroke (−38.7% [95% uncertainty interval: −43.4% to −34.0%]), peripheral arterial disease (−30.1% [−33.5% to −27.2%]), and ischemic heart disease (−28.8% [−32.5% to −25.2%]) showing a declining trend, whereas diabetes (38.2% [29.7%–47.0%]) and high body mass index (25.5% [16.6%–33.7%]) exhibited an increasing trend. Further projection analysis suggested a consistent trend in the changes in CKM syndrome–related burden from 2022 to 2046, with increases ranging from 55.9% for stroke to 105.7% for atrial fibrillation and flutter. Conclusions The findings of this study highlight the substantial and growing CKM syndrome–related burden.
Key Findings
1
From 1990 to 2021, disability-adjusted life-years for all seven key components increased, driven primarily by population growth and population aging.
2
Ischemic heart disease and stroke were the leading contributors to the global cardiovascular-kidney-metabolic syndrome burden in 2021.
3
Lower-sociodemographic-index regions had higher age-standardized disability-adjusted life-year rates than higher-index regions.
4
Southeast Asia and the Western Pacific, representing middle sociodemographic-index regions, experienced the largest overall cardiovascular-kidney-metabolic syndrome burden.
5
The cardiovascular-kidney-metabolic syndrome burden is projected to continue rising through 2046, underscoring the need for targeted interventions.
Research Object
The seven key components of cardiovascular-kidney-metabolic (CKM) syndrome globally: high body mass index, diabetes, chronic kidney disease, atrial fibrillation and flutter, lower extremity peripheral arterial disease, ischemic heart disease, and stroke
Research Subject
The global burden and projected trends of the seven CKM syndrome components, including incidence, prevalence, mortality, DALYs, years lived with disability, years of life lost, and contributions of population growth, aging, and epidemiologic change
Publication Details
Publication Date
2025-03-05
Journal
Publisher
ISSN
Cited by
112
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai9
Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 20192020
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–20192020
Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 20192020
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 20212024
Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 20212023
Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 20212024
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 20212024
Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 20192020
Here’s What to Know About Cardiovascular-Kidney-Metabolic Syndrome, Newly Defined by the AHA2023